Global Contract Bio-manufacturing Organization (CMO) Market Growth (Status and Outlook) 2023-2029

Global Contract Bio-manufacturing Organization (CMO) Market Growth (Status and Outlook) 2023-2029

药品合同生产组织(CMO)是一种新兴外包服务模式,主要接受制药公司的委托,为其提供生产工艺的开发、改进服务以及临床试验和商业化销售药物所用中间体、原料药、制剂的生产供应服务。

LPI (LP Information)' newest research report, the “Contract Bio-manufacturing Organization (CMO) Industry Forecast” looks at past sales and reviews total world Contract Bio-manufacturing Organization (CMO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Contract Bio-manufacturing Organization (CMO) sales for 2023 through 2029. With Contract Bio-manufacturing Organization (CMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contract Bio-manufacturing Organization (CMO) industry.

This Insight Report provides a comprehensive analysis of the global Contract Bio-manufacturing Organization (CMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contract Bio-manufacturing Organization (CMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contract Bio-manufacturing Organization (CMO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contract Bio-manufacturing Organization (CMO) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contract Bio-manufacturing Organization (CMO).

The global Contract Bio-manufacturing Organization (CMO) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Contract Bio-manufacturing Organization (CMO) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Contract Bio-manufacturing Organization (CMO) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Contract Bio-manufacturing Organization (CMO) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Contract Bio-manufacturing Organization (CMO) players cover Abzena, Althea, Asymchem Laboratories Inc., Baxter Biopharma Solutions, Biomeva, Boehringer Ingelheim, Celltrion, AGC Biologics and Cytovance Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Contract Bio-manufacturing Organization (CMO) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Big Bio/Pharma Type
Small/Med Bio/Pharma Type
Virtual/Emerging Type

Segmentation by application
Pharmaceutical Industry
Biotechnology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abzena
Althea
Asymchem Laboratories Inc.
Baxter Biopharma Solutions
Biomeva
Boehringer Ingelheim
Celltrion
AGC Biologics
Cytovance Biologics
Fujifilm Diosynth Technologies
KBI Biopharma
Lonza Group
MicroProtein Technologies
Patheon
Porton Pharma Solutions
Probiogen
Rader
Rentschler Biotechnologie
Samsung
Sandoz
STA Pharmaceutical Co. Ltd

Please note: The report will take approximately 2 business days to prepare and deliver.